A treatment commonly given for anemia, promotes blood-vessel growth in the eye, an effect that could either improve/worsen disease for patients with cancer, diabetic retinopathy, or retinopathy of prematurity. The effects on retinopathy depend on the timing of when the erythropoietin treatment is given.